INCOME STATEMENT
Panacea Biotec Ltd.
BSE
May 13, 02:23
533.35
+18.25 (+ 3.54%)
Volume
69936
Prev. Close
515.10
Open Price
522.00
Bid Price(Qty.)
532.90 (38)
Offer Pr.(Qty.)
534.60 (128)
NSE
May 13, 02:09
533.50
+19.85 (+ 3.86%)
Volume
426175
Prev. Close
513.65
Open Price
520.00
Bid Price(Qty.)
533.50 (100)
Offer Pr.(Qty.)
534.15 (1)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE922B01023
|
Market Cap. ( ₹ in Cr. )
|
3267.73
|
P/BV
|
3.92
|
Book Value ( ₹ )
|
135.98
|
BSE Code
|
531349
|
52 Week High/Low ( ₹ )
|
582/112
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
NSE Code
|
PANACEABIOEQ
|
Book Closure
|
27/09/2024
|
EPS ( ₹ )
|
0.00
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 355.04 | 255.96 | 235.05 | 336.66 | 155.17 |
Other Operating Revenues | 4.57 | 1.11 | 0.46 | 6.89 | 2.91 |
Total Operating Revenues | 359.60 | 257.07 | 235.50 | 343.56 | 158.09 |
| | | | | |
Other Income | 24.91 | 34.44 | 12.57 | 20.75 | 30.88 |
Total Revenue | 384.51 | 291.50 | 248.07 | 364.30 | 188.96 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 123.90 | 131.16 | 172.40 | 68.70 | 75.27 |
Purchase Of Stock-In Trade | 0.00 | 0.75 | 0.64 | 93.33 | 11.44 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 17.79 | 31.15 | -60.95 | 14.24 | -28.18 |
Employee Benefit Expenses | 86.53 | 71.03 | 72.50 | 59.47 | 46.64 |
Finance Costs | 13.78 | 10.06 | 7.04 | 7.52 | 5.27 |
Depreciation And Amortisation Expenses | 21.09 | 24.50 | 26.43 | 26.57 | 26.91 |
Other Expenses | 117.22 | 85.60 | 123.59 | 107.33 | 115.15 |
Total Expenses | 380.31 | 354.25 | 341.65 | 377.16 | 252.49 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 4.21 | -62.75 | -93.58 | -12.85 | -63.53 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -15.40 |
Profit/Loss Before Tax | 4.21 | -62.75 | -93.58 | -12.85 | -78.93 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 0.64 | 0.00 | 0.00 | 2.27 | 39.88 |
Deferred Tax | 0.02 | 24.79 | 0.00 | -0.71 | -22.78 |
Total Tax Expenses | 0.66 | 24.79 | 0.00 | 1.56 | 17.10 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 3.55 | -87.54 | -93.58 | -14.41 | -96.02 |
| | | | | |
Profit/Loss From Continuing Operations | 3.55 | -87.54 | -93.58 | -14.41 | -96.02 |
| | | | | |
Total Tax Expenses Discontinuing Operations | 0.00 | 0.00 | 0.00 | 0.03 | 57.05 |
Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 0.00 | -0.03 | -57.05 |
Profit/Loss For The Period | 3.55 | -87.54 | -93.58 | -14.44 | -153.07 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 0.58 | -14.29 | -15.28 | -2.35 | -24.99 |
Diluted EPS (Rs.) | 0.58 | -14.29 | -15.28 | -2.35 | -24.99 |